$9.71
0.293.08%
al cierre: -
$9.80
0.090.93%
After hour: 6:25 PM EDT
Comments
Loading...
Regenxbio Actividad de operaciones con información privilegiada
RGNXNASDAQ
Actividad de operaciones de insiders
Sigue la actividad de operaciones con información privilegiada más reciente de Regenxbio. Mantente informado sobre las compras, ventas e impacto en el mercado recientes de las acciones de Regenxbio.
¿Qué es la actividad interna?
La actividad de uso de información privilegiada involucra a personas con información privilegiada de la empresa, como ejecutivos, directores y empleados, que participan en transacciones con acciones de su propia empresa. Las transacciones de compra y venta de los iniciados proporcionan información valiosa sobre su confianza en el desempeño futuro de la empresa.
¿Qué están haciendo Regenxbio Inc los iniciados?
Los expertos no han informado de compras ni ventas en los últimos 30 días.
Compras y ventas recientes notables de información privilegiada
No ha habido ninguna compra o venta de información privilegiada en los últimos 90 días.
Estadísticas de propiedad de Regenxbio Inc
Acciones en circulación
50.514M
Acciones en manos de personas con información privilegiada
1.802M
Porcentaje de acciones en manos de personas con información privilegiada
3.57%
Acciones en manos de instituciones
19.377M
Porcentaje de acciones en manos de instituciones
38.4%
May 14, 2025 | — | 0.00 | $5.84 | -$85.58K | SELL-OPTIONS | 0.00% | 475.10K | May 12 | ||
Oct 02, 2024 | — | 0.00 | $6.93 | -$63.45K | SELL-OPTIONS | 0.00% | 11.29K | Oct 01 | ||
Sep 04, 2024 | — | 0.00 | $7.66 | -$77.99K | SELL-OPTIONS | 0.00% | 11.29K | Sep 03 | ||
Aug 05, 2024 | — | 0.00 | $8.68 | -$97.58K | SELL-OPTIONS | 0.00% | 11.29K | Aug 01 | ||
Aug 05, 2024 | CHIEF EXECUTIVE OFFICER | -100.00 | $15.00 | -$1.50K | SELL | -0.06% | 170.04K | Aug 01 | ||
Jul 30, 2024 | — | 0.00 | $13.89 | -$25.36K | SELL-OPTIONS | 0.00% | 11.29K | Jul 29 | ||
Jul 30, 2024 | CHIEF EXECUTIVE OFFICER | -9.65K | $15.04 | -$145.11K | SELL | -5.37% | 170.14K | Jul 29 | ||
Jul 26, 2024 | — | 0.00 | $8.82 | -$279.20K | SELL-OPTIONS | 0.00% | 408.04K | Jul 24 - Jul 25 | ||
Jul 18, 2024 | — | 0.00 | $8.77 | -$24.13K | SELL-OPTIONS | 0.00% | 408.04K | Jul 16 - Jul 17 | ||
Jul 03, 2024 | — | 0.00 | $7.51 | -$75.09K | SELL-OPTIONS | 0.00% | 11.29K | Jul 01 | ||
May 16, 2024 | PRESIDENT AND CEO | 0.00 | $9.79 | -$180.82K | SELL-OPTIONS | 0.00% | 408.04K | May 14 | ||
Apr 17, 2024 | PRESIDENT AND CEO | 0.00 | $10.98 | -$216.47K | SELL-OPTIONS | 0.00% | 408.04K | Apr 15 | ||
Mar 18, 2024 | PRESIDENT AND CEO | 0.00 | $12.81 | -$271.54K | SELL-OPTIONS | 0.00% | 408.04K | Mar 14 | ||
Mar 07, 2024 | CHIEF MEDICAL OFFICER | 0.00 | $25.30 | -$78.68K | SELL-OPTIONS | 0.00% | 107.19K | Mar 05 | ||
Feb 16, 2024 | PRESIDENT AND CEO | 0.00 | $10.26 | -$194.95K | SELL-OPTIONS | 0.00% | 408.04K | Feb 14 | ||
Jan 18, 2024 | PRESIDENT AND CEO | 0.00 | $9.47 | -$513.79K | SELL-OPTIONS | 0.00% | 408.04K | Jan 16 | ||
Jan 04, 2024 | CHIEF MEDICAL OFFICER | 4.43K | $17.60 | -$486.20K | GRANT | 4.31% | 107.19K | Jan 02 - Jan 03 | ||
Dec 21, 2023 | PRESIDENT AND CEO | 0.00 | $11.67 | -$720.99K | SELL-OPTIONS | 0.00% | 355.29K | Dec 19 | ||
Jan 05, 2023 | CHIEF MEDICAL OFFICER | 85.61K | $22.36 | -$111.22K | GRANT | 499.20% | 102.76K | Jan 03 | ||
Aug 31, 2022 | CHIEF FINANCIAL OFFICER | -2.40K | $30.24 | -$72.57K | SELL | -1.74% | 135.16K | Aug 30 | ||
Aug 08, 2022 | CHIEF FINANCIAL OFFICER | -17.68K | $35.18 | -$622.03K | SELL | -11.39% | 137.56K | Aug 04 - Aug 05 | ||
Aug 03, 2022 | CHIEF FINANCIAL OFFICER | -2.40K | $31.25 | -$75.01K | SELL | -1.52% | 155.24K | Aug 01 | ||
Jul 15, 2022 | CHIEF FINANCIAL OFFICER | -4.80K | $30.01 | -$144.03K | SELL | -2.95% | 157.64K | Jul 13 - Jul 14 | ||
Jan 04, 2022 | CHIEF MEDICAL OFFICER | 6.15K | $33.31 | -$91.60K | GRANT | 55.91% | 17.15K | Jan 01 - Jan 03 | ||
Dec 27, 2021 | — | -112.87K | $34.69 | -$3.92M | SELL | -5.76% | 1.84M | Dec 22 - Dec 23 | ||
Nov 10, 2021 | PRESIDENT AND CEO | 0.00 | $21.88 | -$54.36K | SELL-OPTIONS | 0.00% | 280.98K | Nov 08 | ||
Sep 29, 2021 | PRESIDENT AND CEO | 0.00 | $22.97 | -$57.65K | SELL-OPTIONS | 0.00% | 280.98K | Sep 27 | ||
Sep 21, 2021 | DIRECTOR | -48.23K | $45.04 | -$2.17M | SELL | -2.26% | 2.09M | Sep 17 | ||
Sep 15, 2021 | PRESIDENT AND CEO | 0.00 | $24.16 | -$1.56M | SELL-OPTIONS | 0.00% | 280.98K | Sep 13 - Sep 14 | ||
Jun 28, 2021 | PRESIDENT AND CEO | 0.00 | $21.92 | -$217.91K | SELL-OPTIONS | 0.00% | 280.98K | Jun 24 - Jun 25 | ||
Mar 01, 2021 | PRESIDENT AND CEO | 0.00 | $20.81 | -$59.88K | SELL-OPTIONS | 0.00% | 280.98K | Feb 25 | ||
Feb 17, 2021 | CHIEF LEGAL OFFICER | 0.00 | $30.59 | -$173.84K | SELL-OPTIONS | 0.00% | 16.37K | Feb 12 | ||
Feb 10, 2021 | CHIEF LEGAL OFFICER | 0.00 | $30.61 | -$48.11K | SELL-OPTIONS | 0.00% | 16.37K | Feb 08 | ||
Feb 04, 2021 | CHIEF LEGAL OFFICER | 0.00 | $28.44 | -$326.88K | SELL-OPTIONS | 0.00% | 16.37K | Feb 02 | ||
Jan 27, 2021 | PRESIDENT AND CEO | 0.00 | $22.79 | -$285.25K | SELL-OPTIONS | 0.00% | 280.98K | Jan 25 | ||
Jan 20, 2021 | CHIEF FINANCIAL OFFICER | -252.00 | $50.04 | -$12.61K | SELL | -0.22% | 113.64K | Jan 15 | ||
Jan 14, 2021 | CHIEF OPER. & TECH. OFFICER | 0.00 | $41.11 | -$237.12K | SELL-OPTIONS | 0.00% | 17.75K | Jan 12 - Jan 14 | ||
Jan 14, 2021 | CHIEF FINANCIAL OFFICER | -15.29K | $50.02 | -$765.02K | SELL | -11.84% | 113.89K | Jan 12 - Jan 14 | ||
Jan 12, 2021 | CHIEF LEGAL OFFICER | 0.00 | $30.81 | -$745.33K | SELL-OPTIONS | 0.00% | 16.37K | Jan 08 - Jan 12 | ||
Jan 11, 2021 | CHIEF OPER. & TECH. OFFICER | 0.00 | $34.75 | -$158.19K | SELL-OPTIONS | 0.00% | 17.75K | Jan 07 | ||
Jan 11, 2021 | CHIEF FINANCIAL OFFICER | -16.24K | $49.06 | -$796.61K | SELL | -11.17% | 129.19K | Jan 07 - Jan 08 | ||
Jan 11, 2021 | PRESIDENT AND CEO | 0.00 | $25.43 | -$73.74K | SELL-OPTIONS | 0.00% | 281.98K | Jan 07 | ||
Dec 30, 2020 | — | 0.00 | $24.76 | -$310.81K | OPTION EXERCISE | 0.00% | 241.00K | Dec 28 | ||
Dec 28, 2020 | — | -24.50K | $50.01 | -$1.23M | SELL | -15.55% | 133.02K | Dec 23 - Dec 24 | ||
Dec 28, 2020 | — | 0.00 | $25.43 | -$221.18K | OPTION EXERCISE | 0.00% | 241.00K | Dec 23 | ||
Dec 18, 2020 | — | 0.00 | $22.93 | -$662.25K | OPTION EXERCISE | 0.00% | 241.00K | Dec 16 | ||
Dec 14, 2020 | — | -37.50K | $40.10 | -$1.50M | SELL | -19.23% | 157.52K | Dec 10 - Dec 11 | ||
Dec 14, 2020 | — | 0.00 | $20.43 | -$176.18K | OPTION EXERCISE | 0.00% | 241.00K | Dec 10 |
PREGUNTAS FRECUENTES
¿Es legal el uso de información privilegiada?
Las operaciones con información privilegiada son legales siempre que se notifiquen a la Comisión de Bolsa y Valores (SEC). El comercio ilegal de valores se produce cuando la persona con información privilegiada viola un deber fiduciario o no informa de sus operaciones.
¿Cuáles son algunos ejemplos de manipulación del mercado?
Las operaciones con información privilegiada, los esquemas de pump and dump, el front running y las operaciones de lavado son ejemplos de manipulación del mercado. Los inversores que siguen el movimiento de activos con información privilegiada deben pensar atentamente por qué estos operadores con información privilegiada están negociando sus acciones antes de seguir adelante.
Explora operaciones con información privilegiada sobre todos los valores.